Brisbane, CA, United States of America

James Patrick Roane

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.1

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
5 patents (USPTO):

Title: The Innovative Mind of James Patrick Roane

Introduction

James Patrick Roane, an accomplished inventor based in Brisbane, California, has made significant contributions to the field of pharmaceutical sciences. With one patent to his name, Roane's work primarily focuses on advancements in the treatment of various metabolic diseases. His innovative spirit continues to pave the way for essential medical breakthroughs.

Latest Patents

Roane holds a patent for Diacylglyceride O-acyltransferase 2 (DGAT2) inhibitors. This patent encompasses unique compounds of formula I and their pharmaceutically acceptable salts, esters, and prodrugs. The inventions provide methods for producing these compounds, as well as pharmaceutical compositions that incorporate them. The practical applications of his work target treatments for conditions such as hepatic steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, type-2 diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, cognitive decline, dementia, and cardiorenal diseases, which include chronic kidney diseases and heart failure.

Career Highlights

James Patrick Roane is currently associated with Merck Sharp & Dohme Corporation, where he applies his expertise in pharmacology and drug development. His commitment to innovation in healthcare emphasizes the importance of addressing widespread health issues through effective therapies.

Collaborations

Throughout his career, Roane has collaborated with talented coworkers, including Yeon-Hee Lim and Cedric Lorenz Hugelshofer. These partnerships are crucial for fostering creativity and advancing the development of novel pharmaceutical solutions.

Conclusion

James Patrick Roane exemplifies the qualities of a forward-thinking inventor committed to improving health outcomes through scientific innovation. His patent for DGAT2 inhibitors marks a significant development in the medical field, promising potential treatments for various serious conditions. Roane's ongoing dedication to research and collaboration within the pharmaceutical industry underscores the impact inventors can have on the betterment of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…